Merck eyes key cancer drug growth as others lose patent protection Ruby Khatun Khatun5 May 2017 10:38 AM ISTMerck & Co Inc (MRK.N) on Tuesday reported better-than-expected profit in the first quarter as surprisingly strong demand for animal health...
AstraZeneca boosts early respiratory medicine with Pieris deal Ruby Khatun Khatun4 May 2017 11:33 AM ISTAstraZeneca boosted its early-stage respiratory medicine pipeline on Wednesday by signing a deal with Pieris Pharmaceuticals to develop novel inhaled...
Bayer, J&J win first trial over Xarelto bleeding risks Ruby Khatun Khatun4 May 2017 11:27 AM ISTA federal jury has cleared Bayer AG and Johnson & Johnson of liability in the first trial to flow out of thousands of lawsuits blaming injuries on...
Amgen Announces Expanded Commercial Collaboration With Novartis For Erenumab In Migraine Ruby Khatun Khatun4 May 2017 11:27 AM ISTCollaboration Designed to Maximize the Launch of First-in-Class Program and to More Effectively Reach People Living With MigraineTHOUSAND OAKS,...
Visakhapatnam: Two killed in pharma unit fire Ruby Khatun Khatun4 May 2017 11:24 AM ISTVisakhapatnam: Two persons died and three others received burn injuries in a fire at a pharma unit near here on Tuesday, police said.The fire broke...
SeQuent's arm Alivira gets USFDA nod for Visakhapatnam API facility Ruby Khatun Khatun3 May 2017 11:53 AM ISTNew Delhi: Drug firm SeQuent Scientific said its arm Alivira has received approval from the US health regulator for its animal health API facility in...
FDA OKs immune-boosting drug for advanced bladder cancer Ruby Khatun Khatun3 May 2017 10:14 AM ISTTRENTON, N.J.: U.S. regulators have approved a new drug that harnesses the immune system to treat bladder cancer that has spread after chemotherapy...
AstraZeneca immunotherapy wins first approval in bladder cancer Ruby Khatun Khatun3 May 2017 9:23 AM ISTBy Ben Hirschler, Divya and GroverU.S. regulators have approved AstraZeneca's key immunotherapy drug durvalumab as a treatment for bladder cancer,...
FDA approves Radius Health's osteoporosis drug Tymlos Ruby Khatun Khatun2 May 2017 11:14 AM ISTThe U.S. Food and Drug Administration on Friday approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of...
Sun Pharma Science Foundation honours scientists Ruby Khatun Khatun1 May 2017 12:53 PM ISTThe Sun Pharma Science Foundation felicitated Indian scientists with awards for their work and contribution to pharma and medical research.The awards...
U.S. FDA approves Novartis' leukemia treatment Ruby Khatun Khatun1 May 2017 11:36 AM ISTThe U.S. Food and Drug Administration approved Novartis AG's Rydapt as an initial treatment for acute myeloid leukemia (AML) as well as certain other...
USFDA approves Takeda's lung cancer drug as second-line treatment supriya kashyap kashyap1 May 2017 11:36 AM ISTJapan's Takeda Pharmaceutical Co Ltd said that the U.S. Food and Drug Administration approved its lung cancer drug, almost three months after the...
